Biogen Financial Statements From 2010 to 2026

Biogen Balance Sheet		Trends
Current Value Last Year Historical Average  10 Year Trend Total Assets 33.9 B 32.3 B 21.1 B Slightly volatile Short and Long Term Debt Total 8 B 7.6 B 5.1 B Slightly volatile Other Current Liabilities 3.4 B 3.2 B 2.3 B Slightly volatile Total Current Liabilities 6.7 B 6.4 B 3.4 B Slightly volatile Total Stockholder Equity 20.2 B 19.2 B 11.7 B Slightly volatile Property Plant And Equipment Net 4.3 B 4.1 B 2.9 B Slightly volatile Cash 2.9 B 2.7 B 1.7 B Slightly volatile Non Current Assets Total 24.9 B 23.7 B 14.6 B Slightly volatile Non Currrent Assets Other 709.5 M 383.9 M 1.3 B Very volatile Cash And Short Term Investments 1.5 B 2.7 B 2.7 B Slightly volatile Net Receivables 2.3 B 2.1 B 1.7 B Slightly volatile Common Stock Shares Outstanding 124.7 M 131.3 M 203.6 M Slightly volatile Liabilities And Stockholders Equity 33.9 B 32.3 B 21.1 B Slightly volatile Non Current Liabilities Total 7 B 6.7 B 6 B Slightly volatile Other Current Assets 908.6 M 865.4 M 784.3 M Slightly volatile Total Liabilities 13.7 B 13 B 9.3 B Slightly volatile Property Plant And Equipment Gross 7.5 B 7.1 B 3.5 B Slightly volatile Total Current Assets 9 B 8.6 B 6.5 B Slightly volatile Intangible Assets 11.7 B 11.1 B 4.6 B Slightly volatile Accounts Payable 512.2 M 487.8 M 355.8 M Slightly volatile Common Stock Total Equity 85.5 K 90 K 118.7 K Slightly volatile Common Stock 85.5 K 90 K 118.7 K Slightly volatile Short Term Debt 2.1 B 2 B 638.2 M Slightly volatile Inventory 3 B 2.8 B 1.3 B Slightly volatile Other Liabilities 969.6 M 1.5 B 1.4 B Slightly volatile Other Assets 2 B 1.9 B 1.4 B Slightly volatile Long Term Debt 3 B 5.2 B 4.2 B Slightly volatile Property Plant Equipment 2.1 B 3.8 B 2.6 B Slightly volatile Good Will 7.8 B 7.5 B 4.4 B Slightly volatile Net Tangible Assets 4.1 B 6.7 B 4.2 B Slightly volatile Retained Earnings Total Equity 11.5 B 18.9 B 12.2 B Slightly volatile Long Term Debt Total 4.3 B 7.2 B 4.6 B Slightly volatile Capital Surpluse 62.7 M 66 M 1.4 B Slightly volatile Deferred Long Term Liabilities 631.7 M 384.9 M 560.3 M Pretty Stable Non Current Liabilities Other 1 B 842.1 M 982.3 M Slightly volatile Short and Long Term Debt 2.1 B 2 B 658.2 M Slightly volatile Net Invested Capital 19.8 B 26.5 B 18.8 B Pretty Stable Net Working Capital 3.1 B 1.7 B 4 B Slightly volatile Capital Stock 80 K 90 K 98.2 K Slightly volatile Deferred Long Term Asset Charges 3 B 3.7 B 2.7 B Slightly volatile Capital Lease Obligations 295 M 301.1 M 383.7 M Slightly volatile
Biogen Income Statement		Trends
Current Value Last Year Historical Average  10 Year Trend Depreciation And Amortization 812.9 M 774.2 M 540.6 M Slightly volatile Selling General Administrative 2.8 B 2.7 B 2 B Slightly volatile Total Revenue 11.7 B 11.1 B 9.8 B Slightly volatile Gross Profit 8.9 B 8.5 B 8.2 B Slightly volatile Other Operating Expenses 8.7 B 8.3 B 6.3 B Slightly volatile Cost Of Revenue 2.8 B 2.7 B 1.6 B Slightly volatile Total Operating Expenses 5.9 B 5.6 B 4.7 B Slightly volatile Income Tax Expense 395.2 M 314.9 M 749.7 M Pretty Stable Research Development 1.5 B 2.9 B 2.2 B Slightly volatile Net Income Applicable To Common Shares 2 B 3.5 B 2.8 B Slightly volatile Net Income From Continuing Ops 2.8 B 1.9 B 2.7 B Pretty Stable Non Recurring 99.1 M 118 M 121.2 M Pretty Stable Selling And Marketing Expenses 66.6 M 60.1 M 77.5 M Very volatile Tax Provision 234.1 M 246.4 M 930.4 M Slightly volatile Interest Income 106.2 M 77.7 M 98.5 M Very volatile Reconciled Depreciation 525.7 M 605.9 M 820.9 M Slightly volatile
Biogen Cash Flow Statement		Trends
Current Value Last Year Historical Average  10 Year Trend Begin Period Cash Flow 786.4 M 1.2 B 1.4 B Slightly volatile Capital Expenditures 381.3 M 413.8 M 604.2 M Pretty Stable Net Income 1.3 B 1.9 B 2.5 B Very volatile End Period Cash Flow 2.9 B 2.7 B 1.7 B Slightly volatile Stock Based Compensation 201.3 M 334.9 M 181.9 M Slightly volatile
Financial Ratios		Trends
Current Value Last Year Historical Average  10 Year Trend Price To Sales Ratio 2.52 2.65 9.8825 Slightly volatile Dividend Yield 0.0028 0.0023 0.0021 Slightly volatile PTB Ratio 1.46 1.53 5.0805 Slightly volatile Days Sales Outstanding 86.37 81.07 65.902 Slightly volatile Book Value Per Share 108 103 64.0684 Slightly volatile Stock Based Compensation To Revenue 0.0248 0.0346 0.0192 Slightly volatile PB Ratio 1.46 1.53 5.0805 Slightly volatile EV To Sales 3.0 3.15 9.9991 Slightly volatile Inventory Turnover 1.77 1.08 1.4557 Pretty Stable Days Of Inventory On Hand 594 447 307 Pretty Stable Payables Turnover 3.14 4.9 4.7795 Pretty Stable Sales General And Administrative To Revenue 0.16 0.22 0.2051 Pretty Stable Research And Ddevelopement To Revenue 0.52 0.3 0.2753 Pretty Stable Capex To Revenue 0.0406 0.0428 0.0735 Slightly volatile Cash Per Share 15.4 14.67 14.8279 Slightly volatile Interest Coverage 10.87 11.44 37.3959 Slightly volatile Payout Ratio 0.74 0.46 0.4519 Very volatile Days Payables Outstanding 73.21 77.07 84.323 Pretty Stable Intangibles To Total Assets 0.54 0.52 0.3766 Slightly volatile Current Ratio 1.47 1.55 2.435 Slightly volatile Tangible Book Value Per Share 6.44 3.37 14.5074 Pretty Stable Receivables Turnover 6.01 5.95 5.8435 Slightly volatile Graham Number 161 153 133 Slightly volatile Shareholders Equity Per Share 108 103 64.0618 Slightly volatile Debt To Equity 0.19 0.36 0.3825 Slightly volatile Capex Per Share 1.19 2.22 2.8472 Pretty Stable Revenue Per Share 62.76 59.77 52.8121 Slightly volatile Interest Debt Per Share 44.63 42.5 29.7228 Slightly volatile Debt To Assets 0.11 0.21 0.2022 Slightly volatile Short Term Coverage Ratios 1.41 1.48 315 Slightly volatile Operating Cycle 376 413 312 Slightly volatile Price Book Value Ratio 1.46 1.53 5.0805 Slightly volatile Days Of Payables Outstanding 73.21 77.07 84.323 Pretty Stable Dividend Payout Ratio 0.74 0.46 0.4519 Very volatile Ebt Per Ebit 0.62 0.69 0.8884 Slightly volatile Company Equity Multiplier 1.16 1.51 1.7069 Slightly volatile Long Term Debt To Capitalization 0.12 0.19 0.2334 Slightly volatile Total Debt To Capitalization 0.14 0.26 0.2553 Slightly volatile Debt Equity Ratio 0.19 0.36 0.3825 Slightly volatile Quick Ratio 0.99 1.04 2.0878 Slightly volatile Net Income Per E B T 0.92 0.98 0.8079 Slightly volatile Cash Ratio 0.47 0.49 0.8983 Slightly volatile Cash Conversion Cycle 264 353 228 Slightly volatile Days Of Inventory Outstanding 594 447 307 Pretty Stable Days Of Sales Outstanding 86.37 81.07 65.902 Slightly volatile Cash Flow Coverage Ratios 0.47 0.5 1.1491 Slightly volatile Price To Book Ratio 1.46 1.53 5.0805 Slightly volatile Fixed Asset Turnover 2.03 2.46 3.3269 Pretty Stable Debt Ratio 0.11 0.21 0.2022 Slightly volatile Cash Flow To Debt Ratio 0.47 0.5 1.1491 Slightly volatile Price Sales Ratio 2.52 2.65 9.8825 Slightly volatile Asset Turnover 0.33 0.31 0.4672 Slightly volatile Gross Profit Margin 0.5 0.69 0.8097 Slightly volatile Price Fair Value 1.46 1.53 5.0805 Slightly volatile
Biogen Valuation Data		Trends
Current Value Last Year Historical Average  10 Year Trend Market Cap 9.4 B 11.6 B 12 B Pretty Stable Enterprise Value 9.4 B 11.6 B 12 B Pretty Stable

Biogen Fundamental Market Drivers

Biogen Upcoming Events

About Biogen Financial Statements

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Biogen Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Biogen's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Biogen Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Biogen Inc Stock:

How To Invest In Biogen Details

Is Biogen Stock a good investment? Details

What is Biogen's Net Worth? Details

Largest Biotechnology Companies View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies View

Altman Z Score Details

Piotroski F Score Details

Beneish M Score Details

Financial Analysis Details

Buy or Sell Advice Details

Earnings Projections Details